29Aug 2022
Intranasal Corticosteroid Treatment on Recovery of Long‐Term Olfactory Dysfunction Due to COVID‐19

Intranasal Corticosteroid Treatment on Recovery of Long‐Term Olfactory Dysfunction Due to COVID‐19

Olfactory dysfunction is a recognized manifestation in patients infected with COVID‐19. This investigation is aimed to assess the effect of mometasone furoate intranasal spray on the improvement of smell dysfunction in post‐COVID‐19 patients.

  • #ent

Like

Save

Share